MENLO PARK, Calif.--(BUSINESS WIRE)--Apr. 29, 2020--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that company management will participate in three upcoming virtual investor conferences.
- Present at the Bank of America Securities 2020 Health Care Conference scheduled to be held virtually on Thursday, May 14, 2020 at 1:00 p.m. Eastern Time.
- Present at the UBS Virtual Global Healthcare Conference scheduled to be held virtually on Tuesday, May 19, 2020 at 3:50 p.m. Eastern Time.
- Participate at the Oppenheimer’s MedTech Summit scheduled to be held virtually on May 27, 2020.
About Personalis, Inc.
Personalis, Inc. is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis ImmunoID NeXT PlatformTM is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. Personalis also provides genomic information to the VA Million Veterans Program as part of their goal to sequence over a million veteran genomes. The Personalis Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited. For more information, please visit www.personalis.com and follow Personalis on Twitter (@PersonalisInc).
View source version on businesswire.com: https://www.businesswire.com/news/home/20200429005772/en/
Investor Relations Contact:
Caroline Corner
investors@personalis.com
415-202-5678
Media Contact:
Jennifer Havlek
pr@personalis.com
www.personalis.com
650-752-1300
Source: Personalis, Inc.